Sun Pharma acquires three anti-inflammation brands from Aksigen Disperzyme and Phlogam are the first enzyme-bioflavonoid combinations of Trypsin, Bromelain and Rutoside to complete a clinical study in India and get DCGI approval. The brands were registered and launched in India by Aksigen in 2013. https://ift.tt/a6l3UCn
New Drugs Controller General of India likely to be announced soon The top contenders are Dr VG Somani, Dr Rajeev Singh Raghuvanshi and Dr Jai Prakash. Earlier on November 16 last year, the tenure of Dr VG Somani the DCGI was extended by three months for the second time. https://ift.tt/a6l3UCn
Hubby deserts woman whose were kidneys 'stolen' by private hospital in Bihar Muzaffarpur woman Sunita Devi has suffered a double whammy. After the doctors removed both her kidneys fraudulently at a local private nursing home four months back, Sunita's husband has deserted her at this critical juncture when she needed his support the most. https://ift.tt/CjXJYLW
Omicron's XBB.1.5 is mild but effective at entering human cells: Experts Omicron's XBB.1.5, which has been triggering Covid spikes in parts of the US, is comparable to other XBB subvariants in severity, but is less virulent than the Delta and BA2.75 variants of SARS-CoV-2, a study from Pune has found. https://ift.tt/CjXJYLW